FGF/FGFR signaling: From lung development to respiratory diseases

Cytokine Growth Factor Rev. 2021 Dec:62:94-104. doi: 10.1016/j.cytogfr.2021.09.002. Epub 2021 Sep 20.

Abstract

The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) signaling system regulates a variety of biological processes, including embryogenesis, angiogenesis, wound repair, tissue homeostasis, and cancer. It exerts these regulatory functions by controlling proliferation, differentiation, migration, survival, and metabolism of target cells. The morphological structure of the lung is a complex tree-like network for effective oxygen exchange, and the airway terminates in the middle and distal ends of many alveoli. FGF/FGFR signaling plays an important role in the pathophysiology of lung development and pathogenesis of various human respiratory diseases. Here, we mainly review recent advances in FGF/FGFR signaling during human lung development and respiratory diseases, including lung cancer, acute lung injury (ALI), pulmonary arterial hypertension (PAH), chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis.

Keywords: FGF; FGFR; Lung cancer; Lung development; Respiratory diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Fibroblast Growth Factors
  • Humans
  • Lung
  • Neovascularization, Pathologic
  • Pulmonary Disease, Chronic Obstructive*
  • Receptors, Fibroblast Growth Factor*
  • Signal Transduction

Substances

  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factors